Recent advances of stem cell therapy for retinitis pigmentosa

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Genetics

Background:

• Retinitis pigmentosa (RP) is an inherited retinal disorder causing progressive photoreceptor loss, leading to degeneration and atrophy.
• The precise pathogenesis and etiology of RP remain unclear, hindering effective treatment development.
• Current research explores various therapeutic strategies, including animal models and clinical trials.

Purpose of the Study:

• To review the current status of stem cell transplantation for treating RP.
• To highlight the progress and challenges associated with stem cell-based RP therapies.
• To assess the safety and feasibility of using bone marrow-derived mesenchymal stem cells (BMSCs) for clinical application.

Main Methods:

• Literature review of studies on stem cell transplantation in RP.
• Analysis of research focusing on bone marrow-derived mesenchymal stem cells (BMSCs) for RP treatment.
• Evaluation of preclinical and clinical data regarding stem cell therapy for RP.

Main Results:

• Stem cell transplantation, particularly using BMSCs, has emerged as a promising therapeutic avenue for RP.
• Significant progress has been made in preclinical and early clinical studies.
• Challenges remain in optimizing cell delivery, survival, and integration for maximal therapeutic benefit.

Conclusions:

• Stem cell transplantation holds potential for treating retinitis pigmentosa.
• Further research is needed to overcome existing challenges and ensure safety and efficacy for widespread clinical use.
• BMSC transplantation offers a viable option for future RP treatment strategies.